“Li has misled Pfizer about what she took, how she took it, when and why she took it, and where those files (and perhaps others) may be found,” according to the complaint “According to the New York-based pharmaceutical company.
Pfizer announced Li’s resignation after 15 years with the business, and he appears to have accepted an offer to join Xencor Inc, a California clinical-stage company focused on cancer and autoimmune illnesses, on November 29.
Li could not be reached for comment through her LinkedIn account right away. Xencor is not a party to the litigation and has declined to comment.
Pfizer stated that competitors have been “relentlessly” attempting to attract its staff, particularly during 2021.”
Late Tuesday, U.S. District Judge Cathy Ann Bencivengo issued an order temporarily prohibiting Li from utilising Pfizer’s trade secrets and directing the company’s lawyers to check accounts and devices where she may have kept them.
The judge set a hearing for December 9 to consider a longer injunction.
